Invesco Biotechnology & Genome ETF (PBE)

PBE Holdings List

As of May 8, 2025

Filter results

No.	Symbol	Name	% Weight	Shares
1	NTRA	Natera, Inc.	5.74%	75,925
2	NBIX	Neurocrine Biosciences, Inc.	5.59%	102,195
3	GILD	Gilead Sciences, Inc.	4.85%	106,203
4	AMGN	Amgen Inc.	4.75%	37,524
5	UTHR	United Therapeutics Corporation	4.75%	33,135
6	ILMN	Illumina, Inc.	4.58%	123,695
7	BIIB	Biogen Inc.	4.55%	82,559
8	REGN	Regeneron Pharmaceuticals, Inc.	4.17%	16,373
9	PTGX	Protagonist Therapeutics, Inc.	3.76%	184,113
10	BCRX	BioCryst Pharmaceuticals, Inc.	3.60%	779,510
11	HALO	Halozyme Therapeutics, Inc.	3.51%	111,408
12	TGTX	TG Therapeutics, Inc.	3.48%	221,180
13	CPRX	Catalyst Pharmaceuticals, Inc.	3.29%	310,607
14	BPMC	Blueprint Medicines Corporation	3.25%	70,799
15	QGEN	Qiagen N.V.	3.19%	162,590
16	EXAS	Exact Sciences Corporation	3.17%	128,620
17	EXEL	Exelixis, Inc.	2.97%	174,838
18	RPRX	Royalty Pharma plc	2.95%	191,591
19	COLL	Collegium Pharmaceutical, Inc.	2.84%	224,177
20	VCYT	Veracyte, Inc.	2.80%	192,906
21	ACAD	ACADIA Pharmaceuticals Inc.	2.67%	339,519
22	PTCT	PTC Therapeutics, Inc.	2.54%	128,294
23	BMRN	BioMarin Pharmaceutical Inc.	2.52%	90,700
24	MNKD	MannKind Corporation	2.46%	1,142,366
25	INCY	Incyte Corporation	2.41%	86,742
26	TECH	Bio-Techne Corporation	2.33%	100,507
27	CDNA	CareDx, Inc	2.21%	308,964
28	DVAX	Dynavax Technologies Corporation	2.17%	481,349
29	XNCR	Xencor, Inc.	1.83%	446,673
30	MYGN	Myriad Genetics, Inc.	1.03%	549,717
31	AGPXX	Short-Term Investment Trust - Invesco Government & Agency Portfolio	0.06%	137,174
32	n/a	Cash	0.00%	5,728
33	n/a	Securities Lending - Bnym	0.00%	1

As of May 8, 2025